ANDA 65510, held by Watson Labs. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 65510 (Vancomycin Hydrochloride), held by Watson Labs, was first approved by FDA on Apr 9, 2012, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 9, 2012 | Original application | Approved |
| Vancomycin HydrochlorideEQ 125MG BASE · capsule;oral | Vancomycin Hydrochloride | Discontinued |
| Vancomycin HydrochlorideEQ 250MG BASE · capsule;oral | Vancomycin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters